Boston Scientific adds to Rubicon investment

Interventional device developer Boston Scientific of Natick, MA, has made a $15 million investment in Rubicon Medical, a Salt Lake City-based developer and manufacturer of interventional vascular medical devices and products. Coupled with the common shares it received in its July 2003 investment of $2 million, Boston Scientific now owns a total of 18% of Rubicon’s fully diluted equity.

By staff writers
October 30, 2003

Related Reading

Q3 gains reported at Boston Scientific, October 22, 2003

FDA sets date to review Boston Scientific stent, September 16, 2003

Boston Scientific releases Taxus clinical results, September 16, 2003

Boston Scientific’s Taxus stent receives Canadian approval, September 12, 2003

Boston Scientific, CryoVascular form alliance, September 11, 2003

Copyright © 2003

Page 1 of 180
Next Page